Matra basti: Difference between revisions

No edit summary
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 21: Line 21:


|label3 = Reviewer
|label3 = Reviewer
|data3 = Basisht G.<sup>2</sup>,  
|data3 = [[Gopal Basisht|Basisht G.]]<sup>2</sup>,  


|label4 = Editor
|label4 = Editor
|data4 = Deole Y.S.<sup>3</sup>
|data4 = [[Yogesh Deole|Deole Y.S.]]<sup>3</sup>


|label5 = Affiliations
|label5 = Affiliations
Line 85: Line 85:


== Research works with their outcome on Matra Basti ==
== Research works with their outcome on Matra Basti ==
{| class="wikitable"
|+'''Research works on matra basti:'''
!'''S.no.'''
!'''Title'''
!'''Authors'''
!'''Research place'''
!'''Method & Observation'''
!'''Conclusion'''
|-
| style="text-align:center;" |1
|A clinical study of Nirgundi Ghana  Vati & matra basti in the management of Gridhrasi w.s.r. to Sciatica.<ref name="ref8">Ali M, Shukla VD, Dave AR, Bhatt NN. A clinical study of Nirgundi Ghana Vati and Matra Basti in the management of Gridhrasi with special reference to sciatica. Ayu. 2010 Oct;31(4):456-60. doi: 10.4103/0974-8520.82042. PMID: 22048539; PMCID: PMC3202251.</ref>
|Mumtaz Ali, V D Shukla, A R Dave, N  N Bhatt
|Outpatients and inpatients of  Kayachikitsa and Panchakarma Department, Institute of post graduate teaching  and research in Ayurveda, Jamnagar
|
# mild improvement –group A-  59.52%    group B-52%
# moderate improvement –group A-  26.8%    group B-32%
# marked improvement –group A-  13.44%    group B-18%
|In  this research, total 119 patients diagnosed with sciatica. Better results  were obtained in patients who underwent matra basti rather than Nirgundi Ghan  alone.
|-
| style="text-align:center;" |2
|Clinical effect of Matra Basti and Vatari  Guggulu in the management of Amavata (rheumatoid arthritis).<ref name="ref9">Khagram R, Mehta CS, Shukla VD, Dave AR. Clinical effect of Matra Basti and Vatari Guggulu in the management of Amavata (rheumatoid arthritis). Ayu. 2010 Jul;31(3):343-50. doi: 10.4103/0974-8520.77167. PMID: 22131737; PMCID: PMC3221069.</ref>
|Rita Khagram Charmi S  Mehta, V D  Shukla, Alankruta  R Dave
|OPD and IPD Kayachikitsa and  Panchakarma Department, Institute of post graduate teaching and research in  Ayurveda, Jamnagar
|In Matra Basti group, 52%; 26 patients showed marked improvement, while in the Vatari  Guggulu group 54.72%; 29 patients showed mild improvement.
|Total  103 patients completed the treatment for Amavata. Better results were obtained in  patients who underwent Matra Basti rather than Vatari Guggulu alone.
|-
| style="text-align:center;" |3
|A clinical evaluation of Kanchanar Guggulu and Bala Taila Matra Basti in the  management of Mutraghata with special reference to benign prostatic  hyperplasia.<ref name="ref10">Banothe GD, Mahanta V, Gupta SK, Dudhamal TS. A clinical evaluation of Kanchanara Guggulu and Bala Taila Matra Basti in the management of Mutraghata with special reference to benign prostatic hyperplasia. Ayu. 2018 Apr-Jun;39(2):65-71. doi: 10.4103/ayu.AYU_117_15. PMID: 30783359; PMCID: PMC6369605.</ref>
|Gajiram  Dharamdas
Banothe , Vyasdeva  Mahanta, Sanjay  Kumar Gupta, Tukaram  S Dudhamal
|IPGT & RA department of Shalya tantra,  Jamnagar.
|Group A- Bala Taila Matra Basti,
Group B- Bala Taila Matra Basti,  and Kanchanara Guggulu Vati  administered for 21 days.
|Total 32 patients were participated in this  study.
Matra basti along with Kanchanara  Guggulu orally showed comparatively better symptomatic  relief as compared to Matra Basti alone in cases  of Mutraghata (BPH).
|-
| style="text-align:center;" |4
|Efficacy of Kanchanara Guggulu and Matra Basti  of Dhanyaka Gokshura Ghrita in Mootraghata (benign prostatic hyperplasia).<ref name="ref11">Patel JK, Dudhamal TS, Gupta SK, Mahanta V. Efficacy of Kanchanara Guggulu and Matra Basti of Dhanyaka Gokshura Ghrita in Mootraghata (benign prostatic hyperplasia). Ayu. 2015 Apr-Jun;36(2):138-44. doi: 10.4103/0974-8520.175552. PMID: 27011713; PMCID: PMC4784122.</ref>
|Joyal Kumar K Patel , Tukaram S Dudhamal, Sanjay Kumar Gupta, Vyasadeva Mahanta
|OPD and IPD of Shalya Tantra, Jamnagar.
|Group A- Kanchanara Guggulu (500 mg, 3 times  a day orally),
Group B- Dhanyaka Gokshura Ghrita Matra  Basti,
Group C- Kanchanara Guggulu + Dhanyaka  Gokshura Ghrita Matra Basti for 21 days.
# Maximum improvement- 33.34%, 55.56% and  33.34% of patients in Group A, Group B and Group C, respectively.
# Moderate improvement- 44.44% of patients in  all three groups.
# The mild improvement -11.11% and 22.22% in  Group A and Group C, respectively
|Total 30 diagnosed patients of BPH were  selected. They underwent intervention and found maximum imrprovement with  Matra Basti
|-
| style="text-align:center;" |5
|Gokshuradi Vati and Dhanyaka-Gokshura Ghrita  Matra Basti in the management of Benign Prostatic Hyperplasia.<ref name="ref12">Bhalodia SG, Bhuyan C, Gupta SK, Dudhamal TS. Gokshuradi Vati and Dhanyaka-Gokshura Ghrita Matra Basti in the management of Benign Prostatic Hyperplasia. Ayu. 2012 Oct;33(4):547-51. doi: 10.4103/0974-8520.110532. PMID: 23723674; PMCID: PMC3665207.</ref>
|Shreyas G Bhalodia, Chaturbhuj Bhuyan, Sanjay Kumar Gupta, Tukaram S Dudhamal
|OPD and IPD of Shalya Tantra, Jamnagar.
|10  in each group, 21 days of treatment regimen
Group  A-Gokshuradi compound  Vati 500 mg  three times a day with luke-warm water after food;
Group  B- Dhanyaka-Gokshura Ghrita as Matra Basti of 60 ml, once in a day, and combined therapy of both formulations in
Group  C- Gokshuradi compound  Vati + Dhanyaka-Gokshura Ghrita as Matra Basti of 60 ml was  administered.
45.67% improvement was seen in group A,  47.99% in group B, and 54.09% was seen in group C. The size of prostate gland  was found reduced highly significant in group C.
|Maximum improvement was found in the Matra  Basti group.
|-
| style="text-align:center;" |6
|A comparative study of Dashamoola Taila Matra Basti and Tila  Taila Matra Basti in Kashtartava (dysmenorrhea). <ref name="ref13">Karunagoda K, Shukla Upadhyaya K, Donga S, Tanna C, Dei LP. A comparative study of Dashamoola Taila Matra Basti and Tila Taila Matra Basti in Kashtartava (dysmenorrhea). Ayu. 2010 Jul;31(3):305-10. doi: 10.4103/0974-8520.77154. PMID: 22131731; PMCID: PMC3221063.</ref>
|Kaumadi  Karunagoda , Kamayani  Shukla Upadhyaya, Shilpa  Donga, Chandrika  Tanna, L P Dei
|Department of Striroga and Prasuti Tantra,  IPGT and RA, Gujarat Ayurved University, Jamnagar.
|For  the present study, only primary dysmenorrhea was considered under Kashtartava.
|Tila taila matra basti and dashamoola taila matra basti are  both highly effective in primary dysmenorrhea (kashtartava). Dashamoola Taila  Matra Basti also helps to prevent recurrence of  dysmenorrhea.
|-
| style="text-align:center;" |7
|Role of Nasya and Matra Basti with Narayana  Taila on anovulatory factor.<ref name="ref14">Donga KR, Donga SB, Dei LP. Role of Nasya and Matra Basti with Narayana Taila on anovulatory factor. Ayu. 2013 Jan;34(1):81-5. doi: 10.4103/0974-8520.115453. PMID: 24049410; PMCID: PMC3764886.</ref>
|Krupa R  Donga , Shilpa  B Donga, Laxmi  Priya Dei
|OPD/IPD of S.R.P.T. Dept, I.P.G.T & R.A Jamnagar,2014.
|22 patients were completed the study (11 in each group).
|Matra Basti provides significant results over Nasya on anovulatory factor.
|-
| style="text-align:center;" |8
|Effect of shatapushpa taila matra basti and pathadi kwatha on  poly cystic ovarian disease.<ref name="ref15">Patel KD, Dei L, Donga SB, Anand N. Effect of shatapushpa taila matra basti and pathadi kwatha on poly cystic ovarian disease. Ayu. 2012 Apr;33(2):243-6. doi: 10.4103/0974-8520.105245. PMID: 23559797; PMCID: PMC3611647.</ref>
|Krupa D  Patel , Laxmipriya  Dei, Shilpa  B Donga, Nalini  Anand
|OPD/IPD of S.R.P.T. Dept, I.P.G.T & R.A Jamnagar,2014.
|Group 1- 14 patients (Pathadi Kwatha Churna)
Group 2- 12 patients shatapushpa taila matra  basti (STMB)
Group 2 provided  statistically better results  in regularizing menstruation, achieving  considerable reduction in body weight, substantial growth of follicles, and  thus ovulation.
|Treatment with the combination of both Pathadi  Kwatha and Matra Basti has additional effect on the symptoms  of PCOD.
|}